Filing Details

Accession Number:
0000896262-21-000072
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-27 16:30:15
Reporting Period:
2021-05-25
Accepted Time:
2021-05-27 16:30:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896262 Amedisys Inc AMED Services-Home Health Care Services (8082) 113131700
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1694097 Christopher Gerard 3854 American Way, Suite A
Baton Rouge LA 70816
President & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-25 100 $257.35 42,756 No 4 S Direct
Common Stock Disposition 2021-05-25 1,050 $259.69 41,706 No 4 S Direct
Common Stock Disposition 2021-05-25 100 $260.78 41,606 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 279 Indirect Through 401(k) Plan
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.35 to $257.36, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.32 to $260.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  4. The information in this report is based on a plan statement dated as of March 31, 2021.